Home › Sakit sa Coronary Artery › Oklahoma
Pag-aaral pangklinika para sa Sakit sa Coronary Artery sa Oklahoma
7 pag-aaral para sa Sakit sa Coronary Artery ang naghahanap ng mga kalahok sa mga site sa Oklahoma.
Mga Lungsod sa Oklahoma
Opisyal na teksto ng pag-aaral (English)
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
- Oklahoma Heart Hillcrest Medical, Tulsa
Nagre-recruit
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07296744Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- South Oklahoma Heart Research, LLC, Oklahoma City
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06909565A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- South Oklahoma Heart Research, LLC, Oklahoma City
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07521007Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
- Oklahoma City VA Medical Center, Oklahoma City
- Oklahoma Heart Institute at Hillcrest Medical Center, Tulsa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT02061436MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- University of Oklahoma Health Science Center, Oklahoma City
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 11, 2025 · NCT06271590Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
- Oklahoma Heart, Oklahoma City
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update Hul 24, 2025 · NCT04634240MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- Oklahoma University Health (OU Health), Oklahoma City
Nagre-recruit
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Peb 25, 2025 · NCT05908331Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.